By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – French genomic engineering firm Cellectis said on Wednesday it has appointed Wako Pure Chemical Industries as its exclusive distributor in Japan.

Wako will handle sales of Cellectis' products including its Talen Access service, launched in February. In a statement, Luc Selig, vice president of sales and marketing for Cellectis, said that the company is targeting global distribution of Talen, which is a tool for specifically modifying genes in any type of cell.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.